Synergy Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 79   

Articles published

SGYP 4.34 -0.06 (-1.36%)
price chart
Short Interest in Synergy Pharmaceuticals Increases By 20.5% (SGYP)
Currently, 13.3% of the company's shares are short sold. Based on an average daily volume of 1,915,051 shares, the short-interest ratio is currently 5.9 days.
News Recap - Synergy Pharmaceuticals Inc (SGYP), Hercules Offshore, Inc ...  Techsonian (press release)
Related articles »  
Synergy Pharmaceuticals Inc (NASDAQ:SGYP)'s Latest Updates
Dallas, Texas 04/01/2014 (FINANCIALSTRENDS) - Synergy Pharmaceuticals Inc (NASDAQ:SGYP) has been one of the leading pharmaceutical company which are engaged in developing drugs for treating gastrointestinal GI.
News Buzz - Synergy Pharmaceuticals Inc (SGYP), MagneGas Corporation ...  Techsonian (press release)
Top Gainers - Identive Group, Inc.(INVE), Synergy Pharmaceuticals Inc(SGYP ...  REM
Related articles »  
Health Care Equities Analysis -- Research on Raptor Pharma, Intercept Pharma ...
Investor-Edge has initiated coverage on the following equities: Raptor Pharmaceutical Corp. (NASDAQ:RPTP) , Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) , KYTHERA Biopharmaceuticals Inc. (NASDAQ:KYTH) and Synergy Pharmaceuticals Inc.
Related articles »  
Watch List: Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), Catalyst ...
On March 31, 2014, Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) entered into a second amended and restated employment agreement with Kunwar Shailubhai, Ph.
Related articles »  
Synergy Pharmaceuticals Given New $28.00 Price Target at Aegis (SGYP)
Synergy Pharmaceuticals Inc. logo Stock analysts at Aegis lifted their price objective on shares of Synergy Pharmaceuticals (NASDAQ:SGYP) to $28.00 in a report issued on Monday, AR Network reports.
Healthcare Unusual Volume: Dyax Crop. (NASDAQ:DYAX), Synergy ...  Gaining Green
Related articles »  
Synergy Pharmaceuticals Sees Large Growth in Short Interest (SGYP)
Synergy Pharmaceuticals (NASDAQ:SGYP) last announced its earnings results on Monday, March 17th. The company reported ($0.22) earnings per share for the quarter, missing the analysts' consensus estimate of ($0.20) by $0.02.
Healthcare Losers: Achillion Pharmaceuticals (NASDAQ:ACHN), Insmed ...
Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) a developer of new drugs to treat gastrointestinal disorders and diseases, reported its financial results and business update for the fourth quarter and the year ended December 31, 2013.
Related articles »  
Traders Watch List - Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Array ...
Las Vegas, NV - April 15, 2014 - (TechSonian) �Synergy Pharmaceuticals Inc (NASDAQ:SGYP) recently reported its financial results and business update for the fourth quarter and the year ended December 31, 2013.
News Recap: Hercules Offshore, Inc. (HERO), Synergy Pharmaceuticals Inc ...
Las Vegas, NV - April 09, 2014� (TechSonian) �Hercules Offshore, Inc. (HERO) announced that it had received, as of 5:00 p.m.
Related articles »  
Synergy Pharma (SGYP) IBS-C Risk Level Low, Outlook Solid; Aegis Boosts PT ...
Aegis Capital affirms Synergy Pharmaceuticals, Inc. (Nasdaq: SGYP) at Buy and raises its price target from $25 up to $28 following recent Q4 results and IBS-C update.